DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nevanac (Nepafenac Ophthalmic) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (1)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nevanac (Nepafenac Ophthalmic) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Nevanac side effects in 56 year old male

Reported by a physician from Japan on 2012-04-02

Patient: 56 year old male

Reactions: Corneal Exfoliation, Ulcerative Keratitis, Visual Acuity Reduced, Corneal Opacity

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Nevanac
    Dosage: (1 gtt tid ou ophthalmic), (1 gtt qid os ophthalmic)
    Indication: Postoperative Care
    Start date: 2011-08-05
    End date: 2011-11-04

Nevanac
    Dosage: (1 gtt tid ou ophthalmic), (1 gtt qid os ophthalmic)
    Indication: Postoperative Care
    Start date: 2011-06-29
    End date: 2011-07-14

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017